{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:17:59Z","timestamp":1759342679567},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1053\/j.jrn.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T03:16:10Z","timestamp":1508469370000},"page":"474-477","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease"],"prefix":"10.1053","volume":"27","author":[{"given":"Gianluca","family":"Gortan Cappellari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierandrea","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Barazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2017.05.005_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-011-0019-5","article-title":"Wasting in chronic kidney disease","volume":"2","author":"Mak","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1053\/j.jrn.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/ki.2010.520","article-title":"Is ghrelin a biomarker for mortality in end-stage renal disease?","volume":"79","author":"Mak","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000103798","article-title":"Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin","volume":"27","author":"Muscaritoli","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.2015.305","article-title":"Molecular mechanisms of insulin resistance in chronic kidney disease","volume":"88","author":"Thomas","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.jrn.2011.10.017","article-title":"Ghrelin and muscle metabolism in chronic uremia","volume":"22","author":"Barazzoni","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.jrn.2008.11.014","article-title":"Insulin resistance in chronic uremia","volume":"19","author":"Guarnieri","year":"2009","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.jrn.2007.10.015","article-title":"Inflammation and insulin resistance in uremia","volume":"18","author":"Zanetti","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/01.mco.0000172578.56396.9e","article-title":"Kidney insufficiency and nutrient-based modulation of inflammation","volume":"8","author":"Kalantar-Zadeh","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1053\/j.jrn.2017.05.005_bib10","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.05.005_bib12","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2017.05.005_bib13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2017.05.005_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1172\/JCI37048","article-title":"Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans","volume":"119","author":"Anderson","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2017.05.005_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1681\/ASN.2007030355","article-title":"Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD","volume":"19","author":"Ramos","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib16","first-page":"341","article-title":"Muscle glucose content and hexokinase activity in patients with chronic uremia","author":"Fiaschi","year":"1975","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2017.05.005_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000130659","article-title":"Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease","volume":"161","author":"Siew","year":"2008","journal-title":"Contrib Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1681\/ASN.2004100842","article-title":"Chronic kidney disease causes defects in signaling through the insulin receptor substrate\/phosphatidylinositol 3-kinase\/Akt pathway: implications for muscle atrophy","volume":"17","author":"Bailey","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.ki.5001984","article-title":"Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients","volume":"71","author":"Siew","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00075197-200401000-00015","article-title":"Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes","volume":"7","author":"Barazzoni","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1053\/j.jrn.2017.05.005_bib21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/db12-0463","article-title":"Modulating mitochondrial fission to lower diabetic oxidative stress","volume":"61","author":"Barazzoni","year":"2012","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2017.05.005_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"issue":"Suppl 2","key":"10.1053\/j.jrn.2017.05.005_bib23","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2017.05.005_bib24","doi-asserted-by":"crossref","first-page":"E1117","DOI":"10.1152\/ajpendo.00067.2012","article-title":"Insulin fails to enhance mTOR phosphorylation, mitochondrial protein synthesis, and ATP production in human skeletal muscle without amino acid replacement","volume":"303","author":"Barazzoni","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.2009.411","article-title":"Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease","volume":"77","author":"Barazzoni","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib26","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1152\/ajpregu.00745.2006","article-title":"Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease\u2013impact on plasma adiponectin concentration","volume":"293","author":"Barazzoni","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1053\/j.jrn.2017.05.005_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.jrn.2017.05.005_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1079\/BJN20061787","article-title":"Ghrelin: a hormone regulating food intake and energy homeostasis","volume":"96","author":"Gil-Campos","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib30","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1210\/en.2002-220505","article-title":"Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy","volume":"143","author":"Bagnasco","year":"2002","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2017.05.005_bib31","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.peptides.2009.07.002","article-title":"Ghrelin and its therapeutic potential for cachectic patients","volume":"30","author":"Ashitani","year":"2009","journal-title":"Peptides"},{"key":"10.1053\/j.jrn.2017.05.005_bib32","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2017.05.005_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2017.05.005_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0016-5085(03)00281-6","article-title":"Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats","volume":"124","author":"Barazzoni","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.jrn.2017.05.005_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03347409","article-title":"Endogenous ghrelin increases in adriamycin-induced heart failure rats","volume":"30","author":"Xu","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.jrn.2017.05.005_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ndt\/gfg559","article-title":"Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study","volume":"19","author":"Rodriguez Ayala","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.05.005_bib37","doi-asserted-by":"crossref","first-page":"E228","DOI":"10.1152\/ajpendo.00115.2004","article-title":"Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle","volume":"288","author":"Barazzoni","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib38","doi-asserted-by":"crossref","first-page":"e26224","DOI":"10.1371\/journal.pone.0026224","article-title":"High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle","volume":"6","author":"Barazzoni","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2017.05.005_bib39","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1210\/jc.2003-031964","article-title":"Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans","volume":"89","author":"Broglio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib40","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jcem.86.10.8098","article-title":"Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans","volume":"86","author":"Broglio","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib41","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2337\/db14-0407","article-title":"Ghrelin and insulin secretion in humans: not a tale of two hormones?","volume":"63","author":"Barazzoni","year":"2014","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2017.05.005_bib42","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1210\/jc.2006-2527","article-title":"Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome","volume":"92","author":"Barazzoni","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.clnu.2015.10.002","article-title":"Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance","volume":"35","author":"Barazzoni","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib44","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2017.05.005_bib45","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/jc.2004-1069","article-title":"Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes","volume":"90","author":"Gauna","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2017.05.005_bib46","doi-asserted-by":"crossref","first-page":"e000376","DOI":"10.1161\/JAHA.113.000376","article-title":"Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221\/222 expression","volume":"2","author":"Togliatto","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jrn.2017.05.005_bib47","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1038\/ncomms8388","article-title":"AAV-mediated in\u00a0vivo functional selection of tissue-protective factors against ischaemia","volume":"6","author":"Ruozi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1053\/j.jrn.2017.05.005_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2337\/db15-1019","article-title":"Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet induced hyperglycemia and whole-body insulin resistance in rodents","volume":"65","author":"Gortan Cappellari","year":"2016","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2017.05.005_bib49","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1097\/01.ASN.0000032420.12455.74","article-title":"Plasma ghrelin and desacyl ghrelin concentrations in renal failure","volume":"13","author":"Yoshimoto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/089686080702700112","article-title":"Ghrelin in chronic kidney disease: too much or too little?","volume":"27","author":"Mak","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.jrn.2017.05.005_bib51","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/ndt\/gfh313","article-title":"Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis","volume":"19","author":"Perez-Fontan","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.05.005_bib52","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1681\/ASN.2005010039","article-title":"Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial","volume":"16","author":"Wynne","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.005_bib53","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1210\/en.2015-1353","article-title":"Improvement of physical decline through combined effects of muscle enhancement and mitochondrial activation by a gastric hormone ghrelin in male 5\/6Nx CKD model mice","volume":"156","author":"Tamaki","year":"2015","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2017.05.005_bib54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","article-title":"Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile","volume":"149","author":"Deboer","year":"2008","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2017.05.005_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clnu.2007.06.013","article-title":"Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients","volume":"27","author":"Barazzoni","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1053\/j.jrn.2017.05.005_bib56","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2215\/CJN.09170912","article-title":"Association of plasma des-acyl ghrelin levels with CKD","volume":"8","author":"Gupta","year":"2013","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617301218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617301218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T05:05:34Z","timestamp":1603170334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227617301218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1051227617301218"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2017.05.005","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}